Trade Summary

5 days ago, Gold Daniel Allen, serving as Dir at Roivant Sciences Ltd. (ROIV), sold 1,438,163 shares at $34.32 per share, for a total transaction value of $49,354,075.76. Following this transaction, Gold Daniel Allen now holds 13,689,166 shares of ROIV.

This sale represents a 9.51% decrease in Gold Daniel Allen's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, June 26, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, July 1, 2026 (accepted Jun 30, 8:30 PM ET), 5 days after the trade was made.

Roivant Sciences Ltd. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.